SkinCo

SkinBioTherapeutics is a life science company focused on the development of proprietary technology that harnesses the human microbiome to improve skin health. The company's core platform, SkinBiotix, utilizes probiotic lysates to enhance the skin's barrier function, protect against infection, and promote wound healing. Its commercial portfolio includes AxisBiotix-Ps, a probiotic food supplement designed to manage the symptoms of psoriasis, and Zenakine, a cosmetic ingredient partnered with Croda. SkinBioTherapeutics is actively expanding its pipeline into areas such as acne, eczema, and hospital-acquired infections while integrating strategic acquisitions like Dermatonics and Bio-Tech Solutions to strengthen its manufacturing and distribution capabilities.